Vagifem®
:Hormone replacement therapy
:Filed for registration
An ultra-low-dose version of Vagifem®, a local oestrogen therapy, which is intended for effective relief of symptoms associated with vaginal dryness, such as painful intercourse, itching, burning and soreness.
- Company announcements
- Novo Nordisk disputes Pfizer’s attempted termination of US hormone replacement therapy agreement (30 May 2003)
- Financial statement for the first half of 2001 (07 Aug 2001)
- Financial statement for the first quarter of 2001 (08 May 2001)
- Read more company announcements
- Press releases
- Novo Nordisk assumes US marketing of Activella® and Vagifem® immediately (21 Jul 2003)
- Read more press releases
- Scientific abstracts
- Journal of Pharmaceutical and Biomedical Analysis (2004)
- Read more scientific abstracts
